Edgar Deu

1.2k total citations
28 papers, 900 citations indexed

About

Edgar Deu is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Edgar Deu has authored 28 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Edgar Deu's work include Peptidase Inhibition and Analysis (12 papers), Malaria Research and Control (12 papers) and Enzyme Structure and Function (5 papers). Edgar Deu is often cited by papers focused on Peptidase Inhibition and Analysis (12 papers), Malaria Research and Control (12 papers) and Enzyme Structure and Function (5 papers). Edgar Deu collaborates with scholars based in United States, United Kingdom and Netherlands. Edgar Deu's co-authors include Matthew Bogyo, Martijn Verdoes, Victoria E. Albrow, Jack F. Kirsch, Elizabeth L. Ponder, Christopher J. Kirk, Susan D. Demo, Jonathan A. Ellman, Melissa J. Leyva and Guy S. Salvesen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Edgar Deu

27 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar Deu United States 17 478 282 221 136 114 28 900
Michael B. Harbut United States 11 462 1.0× 242 0.9× 213 1.0× 134 1.0× 150 1.3× 13 915
Keith H. Ansell United Kingdom 15 370 0.8× 415 1.5× 132 0.6× 141 1.0× 73 0.6× 18 949
Jeffrey L. Klaus United States 7 426 0.9× 197 0.7× 192 0.9× 239 1.8× 59 0.5× 8 905
Nyssa Drinkwater Australia 18 318 0.7× 142 0.5× 206 0.9× 101 0.7× 57 0.5× 36 648
Maria Helena S. Cezari Brazil 19 449 0.9× 151 0.5× 185 0.8× 129 0.9× 36 0.3× 27 884
James Delproposto United States 12 782 1.6× 297 1.1× 226 1.0× 48 0.4× 210 1.8× 14 1.2k
John R. Somoza United States 20 765 1.6× 88 0.3× 114 0.5× 211 1.6× 136 1.2× 35 1.2k
Euna Yoo United States 16 381 0.8× 126 0.4× 122 0.6× 290 2.1× 69 0.6× 30 892
Sharon Yeoh United Kingdom 15 640 1.3× 647 2.3× 273 1.2× 82 0.6× 51 0.4× 23 1.6k
Jessica L. Bridgford Australia 9 308 0.6× 455 1.6× 116 0.5× 68 0.5× 87 0.8× 9 866

Countries citing papers authored by Edgar Deu

Since Specialization
Citations

This map shows the geographic impact of Edgar Deu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Deu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Deu more than expected).

Fields of papers citing papers by Edgar Deu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Deu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Deu. The network helps show where Edgar Deu may publish in the future.

Co-authorship network of co-authors of Edgar Deu

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Deu. A scholar is included among the top collaborators of Edgar Deu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Deu. Edgar Deu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howell, Steven, et al.. (2022). Activity-based protein profiling of human and plasmodium serine hydrolases and interrogation of potential antimalarial targets. iScience. 25(9). 104996–104996. 6 indexed citations
2.
Dalen, Floris J. van, et al.. (2021). Application of a Highly Selective Cathepsin S Two-step Activity-Based Probe in Multicolor Bio-Orthogonal Correlative Light-Electron Microscopy. Frontiers in Chemistry. 8. 628433–628433. 8 indexed citations
3.
Sánchez, Mateo I., et al.. (2020). Novel broad-spectrum activity-based probes to profile malarial cysteine proteases. PLoS ONE. 15(1). e0227341–e0227341. 9 indexed citations
4.
Sánchez, Mateo I., Christine Lehmann, Kenny K. H. Ang, et al.. (2019). Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening. PLoS ONE. 14(12). e0226270–e0226270. 6 indexed citations
5.
Lehmann, Christine, et al.. (2018). Plasmodium falciparum dipeptidyl aminopeptidase 3 activity is important for efficient erythrocyte invasion by the malaria parasite. PLoS Pathogens. 14(5). e1007031–e1007031. 27 indexed citations
6.
Thomas, J. Alero, Christine R. Collins, Sujaan Das, et al.. (2016). Development and Application of a Simple Plaque Assay for the Human Malaria Parasite Plasmodium falciparum. PLoS ONE. 11(6). e0157873–e0157873. 52 indexed citations
7.
Tanaka, Takeshi, Edgar Deu, Alvaro Molina-Cruz, et al.. (2013). Plasmodium Dipeptidyl Aminopeptidases as Malaria Transmission-Blocking Drug Targets. Antimicrobial Agents and Chemotherapy. 57(10). 4645–4652. 22 indexed citations
8.
Stolze, Sara Christina, Edgar Deu, Farnusch Kaschani, et al.. (2012). The Antimalarial Natural Product Symplostatin 4 Is a Nanomolar Inhibitor of the Food Vacuole Falcipains. Chemistry & Biology. 19(12). 1546–1555. 62 indexed citations
9.
Li, Hao, Elizabeth L. Ponder, Martijn Verdoes, et al.. (2012). Validation of the Proteasome as a Therapeutic Target in Plasmodium Using an Epoxyketone Inhibitor with Parasite-Specific Toxicity. Chemistry & Biology. 19(12). 1535–1545. 69 indexed citations
10.
Deu, Edgar, Martijn Verdoes, & Matthew Bogyo. (2012). New approaches for dissecting protease functions to improve probe development and drug discovery. Nature Structural & Molecular Biology. 19(1). 9–16. 126 indexed citations
11.
Albrow, Victoria E., Elizabeth L. Ponder, Domenico Fasci, et al.. (2011). Development of Small Molecule Inhibitors and Probes of Human SUMO Deconjugating Proteases. Chemistry & Biology. 18(6). 722–732. 60 indexed citations
12.
Mahajan, Sumit, Edgar Deu, Melissa J. Leyva, et al.. (2011). A Fragmenting Hybrid Approach for Targeted Delivery of Multiple Therapeutic Agents to the Malaria Parasite. ChemMedChem. 6(3). 415–419. 25 indexed citations
13.
14.
Suzuki, Érika, Susan D. Demo, Edgar Deu, et al.. (2011). Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells. PLoS ONE. 6(12). e27996–e27996. 62 indexed citations
15.
Ponder, Elizabeth L., Victoria E. Albrow, Miklós Békés, et al.. (2011). Functional Characterization of a SUMO Deconjugating Protease of Plasmodium falciparum Using Newly Identified Small Molecule Inhibitors. Chemistry & Biology. 18(6). 711–721. 40 indexed citations
16.
Puri, Aaron W., Patrick J. Lupardus, Edgar Deu, et al.. (2010). Rational Design of Inhibitors and Activity-Based Probes Targeting Clostridium difficile Virulence Factor TcdB. Chemistry & Biology. 17(11). 1201–1211. 51 indexed citations
17.
Deu, Edgar, Melissa J. Leyva, Victoria E. Albrow, et al.. (2010). Functional Studies of Plasmodium falciparum Dipeptidyl Aminopeptidase I Using Small Molecule Inhibitors and Active Site Probes. Chemistry & Biology. 17(8). 808–819. 50 indexed citations
18.
Deu, Edgar, et al.. (2010). Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1. Molecular and Biochemical Parasitology. 175(1). 10–20. 33 indexed citations
19.
Deu, Edgar, et al.. (2010). Use of Activity-Based Probes to Develop High Throughput Screening Assays That Can Be Performed in Complex Cell Extracts. PLoS ONE. 5(8). e11985–e11985. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026